PMV PHARMACEUTICALS INC (PMVP) Stock Income Statement
NASDAQ:PMVP - Nasdaq - US69353Y1038 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 85.45M | 80.13M | 77.04M | 58.29M | 34.94M | |||
| Research and Development | 58.53M | 55.88M | 51.99M | 36.49M | 23.93M | |||
| Selling, General, and Administrative Expenses | 26.92M | 24.25M | 25.05M | 21.80M | 11.01M | |||
| Operating Income | -85.45M | -80.13M | -77.04M | -58.29M | -34.94M | |||
| Interest Income/Expense | 10.65M | 11.17M | 3.63M | 450.00K | 650.00K | |||
| Other Income/Expense | -16.00K | 3.00K | 90.00K | 20.00K | -140.00K | |||
| Income Before Taxes | -74.81M | -68.96M | -73.33M | -57.82M | -34.43M | |||
| Income Tax | -16.10M | 2.00K | -10.00K | 20.00K | 10.00K | |||
| Net Income | -58.71M | -68.96M | -73.32M | -57.85M | -34.44M | |||
| EBITDA | -84.30M | -78.88M | -76.72M | -57.98M | -34.62M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.14 | -1.44 | -1.61 | -1.28 | -0.77 | |||
| Non GAAP EPS | -1.14 | -1.45 | -1.62 | -1.28 | N/A | |||
| Statistics | ||||||||
All data in USD